Anti-TNF therapy significantly improves growth disturbances in pediatric Crohn’s

LAS VEGAS — Although a substantial proportion of children with Crohn’s disease had growth disturbances at initiation of anti-tumor necrosis factor therapy, “significant improvement” was noted up to 24 months after treatment, data showed.
“It has been noted that growth failure impacts 15% to 40% of those with Crohn’s disease, with some studies showing that up to one quarter of children with Crohn’s disease will not achieve their full growth potential,” Natalia Plott, MD, a second-year pediatric gastroenterology fellow at Riley Hospital for

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart